298 related articles for article (PubMed ID: 32557174)
1. Anti-inflammatory Activity of Bioactive Compounds from Microalgae and Cyanobacteria by Focusing on the Mechanisms of Action.
Tabarzad M; Atabaki V; Hosseinabadi T
Mol Biol Rep; 2020 Aug; 47(8):6193-6205. PubMed ID: 32557174
[TBL] [Abstract][Full Text] [Related]
2. Bioactive peptides from marine sources as potential anti-inflammatory therapeutics.
Kim JA; Kim SK
Curr Protein Pept Sci; 2013 May; 14(3):177-82. PubMed ID: 23721313
[TBL] [Abstract][Full Text] [Related]
3. Bioprospecting microalgae and cyanobacteria for biopharmaceutical applications.
Saeed MU; Hussain N; Shahbaz A; Hameed T; Iqbal HMN; Bilal M
J Basic Microbiol; 2022 Sep; 62(9):1110-1124. PubMed ID: 34914840
[TBL] [Abstract][Full Text] [Related]
4. Anti-Inflammatory, Antioxidant, and Wound-Healing Properties of Cyanobacteria from Thermal Mud of Balaruc-Les-Bains, France: A Multi-Approach Study.
Demay J; Halary S; Knittel-Obrecht A; Villa P; Duval C; Hamlaoui S; Roussel T; Yéprémian C; Reinhardt A; Bernard C; Marie B
Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33383796
[No Abstract] [Full Text] [Related]
5. Cyanobacteria and Eukaryotic Microalgae as Emerging Sources of Antibacterial Peptides.
Rojas V; Rivas L; Cárdenas C; Guzmán F
Molecules; 2020 Dec; 25(24):. PubMed ID: 33316949
[TBL] [Abstract][Full Text] [Related]
6. Unlocking the Health Potential of Microalgae as Sustainable Sources of Bioactive Compounds.
Saide A; Martínez KA; Ianora A; Lauritano C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922258
[TBL] [Abstract][Full Text] [Related]
7. Phytoplankton of the Curonian Lagoon as a New Interesting Source for Bioactive Natural Products. Special Impact on Cyanobacterial Metabolites.
Overlingė D; Toruńska-Sitarz A; Cegłowska M; Błaszczyk A; Szubert K; Pilkaitytė R; Mazur-Marzec H
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439804
[TBL] [Abstract][Full Text] [Related]
8. Microalgae Bioactive Compounds to Topical Applications Products-A Review.
Martínez-Ruiz M; Martínez-González CA; Kim DH; Santiesteban-Romero B; Reyes-Pardo H; Villaseñor-Zepeda KR; Meléndez-Sánchez ER; Ramírez-Gamboa D; Díaz-Zamorano AL; Sosa-Hernández JE; Coronado-Apodaca KG; Gámez-Méndez AM; Iqbal HMN; Parra-Saldivar R
Molecules; 2022 May; 27(11):. PubMed ID: 35684447
[TBL] [Abstract][Full Text] [Related]
9. Microalgae with Immunomodulatory Activities.
Riccio G; Lauritano C
Mar Drugs; 2019 Dec; 18(1):. PubMed ID: 31861368
[TBL] [Abstract][Full Text] [Related]
10. Microalgae as a source of high-value bioactive compounds.
Bule MH; Ahmed I; Maqbool F; Bilal M; Iqbal HMN
Front Biosci (Schol Ed); 2018 Jan; 10(2):197-216. PubMed ID: 28930527
[TBL] [Abstract][Full Text] [Related]
11. Cyanobacteria and microalgae bioactive compounds in skin-ageing: potential to restore extracellular matrix filling and overcome hyperpigmentation.
Favas R; Morone J; Martins R; Vasconcelos V; Lopes G
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1829-1838. PubMed ID: 34353202
[TBL] [Abstract][Full Text] [Related]
12. Biologically active secondary metabolites from marine cyanobacteria.
Nunnery JK; Mevers E; Gerwick WH
Curr Opin Biotechnol; 2010 Dec; 21(6):787-93. PubMed ID: 21030245
[TBL] [Abstract][Full Text] [Related]
13. Biotechnological Applications of Bioactive Peptides From Marine Sources.
Giordano D; Costantini M; Coppola D; Lauritano C; Núñez Pons L; Ruocco N; di Prisco G; Ianora A; Verde C
Adv Microb Physiol; 2018; 73():171-220. PubMed ID: 30262109
[TBL] [Abstract][Full Text] [Related]
14. Exploring marine resources for bioactive compounds.
Kiuru P; DʼAuria MV; Muller CD; Tammela P; Vuorela H; Yli-Kauhaluoma J
Planta Med; 2014 Sep; 80(14):1234-46. PubMed ID: 25203732
[TBL] [Abstract][Full Text] [Related]
15. Bioactive substances of cyanobacteria and microalgae: Sources, metabolism, and anticancer mechanism insights.
Bouyahya A; Bakrim S; Chamkhi I; Taha D; El Omari N; El Mneyiy N; El Hachlafi N; El-Shazly M; Khalid A; Abdalla AN; Goh KW; Ming LC; Goh BH; Aanniz T
Biomed Pharmacother; 2024 Jan; 170():115989. PubMed ID: 38103309
[TBL] [Abstract][Full Text] [Related]
16. Isolation of Industrial Important Bioactive Compounds from Microalgae.
Balasubramaniam V; Gunasegavan RD; Mustar S; Lee JC; Mohd Noh MF
Molecules; 2021 Feb; 26(4):. PubMed ID: 33579001
[TBL] [Abstract][Full Text] [Related]
17. Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer's Disease.
Castaneda A; Ferraz R; Vieira M; Cardoso I; Vasconcelos V; Martins R
Mar Drugs; 2021 Jun; 19(6):. PubMed ID: 34208482
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of the novel bioactive compounds from microalgae and cyanobacteria for pharmaceutical and nutraceutical applications.
Hassan S; Meenatchi R; Pachillu K; Bansal S; Brindangnanam P; Arockiaraj J; Kiran GS; Selvin J
J Basic Microbiol; 2022 Sep; 62(9):999-1029. PubMed ID: 35014044
[TBL] [Abstract][Full Text] [Related]
19. Marine Algae of the Genus Gracilaria as Multi Products Source for Different Biotechnological and Medical Applications.
Nabil-Adam A; Shreadah MA; Abd El-Moneam NM; El-Assar SA
Recent Pat Biotechnol; 2020; 14(3):203-228. PubMed ID: 31987028
[TBL] [Abstract][Full Text] [Related]
20. Marine natural products with anti-inflammatory activity.
Cheung RCF; Ng TB; Wong JH; Chen Y; Chan WY
Appl Microbiol Biotechnol; 2016 Feb; 100(4):1645-1666. PubMed ID: 26711278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
